Abstract The rapid advancements in genomics research offer significant promise for revolutionizing healthcare, potentially reshaping how we approach disease prevention, diagnosis, and treatment. However, unlocking the full potential of genomics requires more than just scientific breakthroughs-it necessitates translating these discoveries into clinical practice. This involves bridging the gap between research and healthcare implementation, addressing challenges such as technical infrastructure, ethical and legal frameworks, healthcare professional competencies, and citizen engagement. As we navigate the evolving landscape of individualized patient care, it becomes increasingly crucial to implement effective risk stratification methodologies and personalized preventive measures. Among these methodologies, polygenic risk scores are gaining prominence. However, the adoption of these innovations necessitates careful consideration of their clinical utility, including their feasibility, cost-effectiveness, and acceptability in diverse healthcare settings. Validating these approaches from multiple perspectives is essential to ensure their effectiveness in real-world clinical practice. Integrating genomic sequencing data with health records presents an invaluable resource that can enhance patient outcomes and drive further research. The creation of infrastructures and initiatives such as those carried out by projects like the European Health Data Space and Genomic Data Infrastructure are fundamental to unleash the enormous potential of data-driven innovation. To date, the implementation of genomics in medical practice varies across European countries, with discrepancies in adoption levels across different aspects of healthcare, including prevention, diagnosis, and personalized treatment. Addressing these disparities and promoting standardized approaches to genomic medicine implementation are crucial steps toward ensuring equitable access and maximizing the benefits of genomics for all individuals across Europe. This workshop aims to provide decision-makers, healthcare professionals and researchers with a comprehensive overview of the state-of-the-art for the adoption of personalized approaches, and of the maturity of genomic medicine practices within different healthcare systems as well outlining the benefits of data accessibility for research. The speakers are coordinators and partners of EU projects as B1MG (Beyond One Million Genomes), Prophet (A PeRsOnalized Prevention roadmap for the future Healthcare), EHDS (European Health Data Space), GDI (European Genomic Data Infrastructure), GoE (Genome of Europe) and CanHeal. Key messages • Genomics has the potential to improve health outcomes. • Equal access to genomic medicine critical for personalized health. Ensuring equity, while considering feasibility.